Table 1 Visual function endpoints.

From: Development and standardisation of ‘time-in-range’ measurement for clinical endpoints in retinal diseases

Endpoint

Test

Indications

Advantages

Disadvantages

BCVA

BCVA score

Mean change in BCVA [21] Percentage of VA gain (>0, >5,

>10, >15 letters)

Percentage with VA >20/40 [50]

All ocular diseases

Widespread; inexpensive, rapid and intuitive to perform and understand; possibly self-administered; correlates with quality of life

Limited value in early disease and tracking small changes; does not consider BCVA changes during the study period

LLVA

LLVA score [27]

Mean change in LLVA [20]

AMD, DMO, DR, CSCR, IRD

Simple, inexpensive and rapid; possibly self-administered

Selected information (foveal function); related to the timepoint assessed

Contrast sensitivity

Contrast sensitivity level (e.g., number of triplets on Pelli-Robson charts)

Change in contrast sensitivity [20]

AMD, DMO, DR, refractive surgery, CSCR, IRD

Rapid and correlates with quality of life

Difficult to set up accurately; limited sensitivity; not well standardised and widespread; related to the timepoint assessed

Perimetry

Mean sensitivity and mean deviation [1]

Glaucoma, neurological conditions, retinal diseases

Comprehensive measure of visual function

Need for adequate instruments and time; influenced by the conditions of execution and the patient’s learning curve

Microperimetry

Scotopic/mesopic sensitivity [20]

AMD, DMO, vitreoretinal disorders, retinotoxicity disorders, macular dystrophies, IRD

Better understanding of morphology and function; particularly used to determine fixation in advanced AMD

Not widespread; long testing duration; related to the timepoint assessed; learning curve

Dark adaptometry

Change in visual performance [20, 21]

AMD, DMO, DR

To differentiate AMD from variants of genetic disease

Early diagnosis of AMD progression if short-duration testing strategies prove effective

Assesses photoreceptor dynamic response

Need for adequate instruments and time; lack of standardisation; related to the timepoint assessed

Reading speed

Mean change in reading speed [20]

AMD, DMO, vitreoretinal disorders, refractive surgery

Strongly linked to vision-related quality of life

Lack of standardisation and agreement on methodology; dependent on patient literacy; related to the timepoint assessed

  1. AMD age-related macular degeneration, BCVA best corrected visual acuity, CSCR central serous chorioretinopathy, DMO diabetic macular oedema, DR diabetic retinopathy, IRD inherited retinal diseases, LLVA low-luminance visual acuity, VA visual acuity.